Sodium phenylbutyrate induces apoptosis in human retinoblastoma Y79 cells: the effect of combined treatment with the topoisomerase I-inhibitor topotecan.

International journal of oncology

Volumn 18, Issue 6, 2001, Pages 1233-1237

  Calvaruso, G ^a   Carabillo M ^a   Giuliano, M ^a   Lauricella, M ^a   D'Anneo, A ^a   Vento, R ^a   Tesoriere, G ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARYLBUTYRIC ACID DERIVATIVE; CASP3 PROTEIN, HUMAN; CASPASE; CASPASE 3; DNA TOPOISOMERASE; ENZYME INHIBITOR; HISTONE; PROTEIN BCL 2; PROTEIN P53; TOPOTECAN;

ACETYLATION; APOPTOSIS; ARTICLE; CELL CULTURE; CELL SURVIVAL; DRUG ANTAGONISM; DRUG COMBINATION; DRUG EFFECT; DRUG POTENTIATION; ENZYME ACTIVATION; ENZYMOLOGY; HUMAN; METABOLISM; PATHOLOGY; RETINOBLASTOMA; WESTERN BLOTTING;

ACETYLATION; APOPTOSIS; BLOTTING, WESTERN; CASPASE 3; CASPASES; CELL SURVIVAL; DNA TOPOISOMERASES, TYPE I; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; ENZYME ACTIVATION; ENZYME INHIBITORS; HISTONES; HUMANS; PHENYLBUTYRATES; PROTO-ONCOGENE PROTEINS C-BCL-2; RETINOBLASTOMA; TOPOTECAN; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

MLCS; MLOWN;

EID: 0035378243     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.18.6.1233     Document Type: Article

References (0)